NCT05610020View on ClinicalTrials.gov

Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity

CompletedOBSERVATIONAL

Enrollment

55

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

October 1, 2022

Conditions

SepsisHBP

Trial Locations (1)

61511

Omar Hamdy, Minya

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT05610020 - Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity | Biotech Hunter | Biotech Hunter